VOLITIONRX LTD Cash And Cash Equivalents At Carrying Value

Quick Answer

VOLITIONRX LTD reported Cash And Cash Equivalents At Carrying Value of $20.73 million for the year ending 2023.

  • VOLITIONRX LTD showed an increase of +90.8% in Cash And Cash Equivalents At Carrying Value from 2022 to 2023.
  • This data is from VOLITIONRX LTD's annual report (Form 10-K), filed with the SEC on March 25, 2024.
  • XBRL data for this metric is available from 2010 to 2023 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 13 years of available data (2010 to 2023), VOLITIONRX LTD's Cash And Cash Equivalents At Carrying Value has grown by 43,559.5%.
  • Historical annual values: Fiscal year 2023: $20.73 million | Fiscal year 2022: $10.87 million | Fiscal year 2021: $20.58 million | Fiscal year 2020: $19.44 million | Fiscal year 2019: $16.97 million | Fiscal year 2018: $13.43 million | Fiscal year 2017: $10.12 million | Fiscal year 2016: $21.68 million | Fiscal year 2015: $5.92 million | Fiscal year 2014: $2.14 million | Fiscal year 2012: $376.4 thousand | Fiscal year 2011: $347.9 thousand | Fiscal year 2010: $47.5 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: